Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation

Aim. To evaluate the budgetary impact of using budesonide + formoterol (Symbicort Turbuhaler) as maintenance therapy in real clinical practice compared with standard therapy for asthma of varying severity: for mild asthma with on-demand salbutamol; for moderate and severe asthma with the drug salme...

Full description

Bibliographic Details
Main Authors: Sergey K. Zyryanov, Ilya N. Dyakov, Zaurbek R. Aisanov
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2022-08-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/109735/83978